Top Stories

AIM: Electronic prep, CTC could improve colon cancer screening

Monday, May 14
colon cancer - 204.89 Kb
Laxative-free CT colonography (CTC) provided reasonable accuracy in the detection of adenomas 10 mm or larger and improved patient comfort compared with optical colonoscopy, according to a study published May 15 in Annals of Internal Medicine.

JNM: SPECT tracer shines light on lung malignancies

Thursday, May 10
lungs - 84.62 Kb
99mTc-3PRGD2, a new SPECT tracer that targets integrin xvB3 receptor, is sensitive for the detection of lung cancer, according to a study published in the May issue of The Journal of Nuclear Medicine.

FDA recommends imaging vendors demonstrate pediatric safety

Wednesday, May 09
FDA logo - 10.14 Kb
The FDA has issued a draft guidance outlining its current thinking regarding information that should be included in premarket notifications for x-ray imaging devices with indications for use in pediatric populations.

ASBrS: Time to pull the plug on thermography for breast screening?

Monday, May 07
plug - 60.05 Kb
Infrared thermography is not a reliable breast cancer screening tool, according to a study presented at the American Society of Breast Surgeons (ASBrS) annual meeting in Phoenix, May 2-6.

Study: Breast brachytherapy may be best for local tumor control

Friday, May 04
cells - 323.90 Kb
Accelerated partial breast irradiation is more effective in preventing local breast cancer recurrence than whole breast irradiation, according to a study presented at the American Society of Breast Surgeons (ASBrS) annual meeting in Phoenix, May 2-6.

PORTAL TOPICS

Bone Imaging

Gastrointestinal/Renal Imaging

Lymphoma

Men’s Imaging

Neuroimaging

Pediatric Imaging

Thoracic Imaging

Women’s Imaging

Latest News


JNM: HER2-targeting affibody bests FDG for imaging pulmonary metastases

Clinical Studies | Monday, May 14
Metastasis Growth in Mouse Breast Cancer Model - 123.95 Kb
An affibody which targets human epidermal growth factor receptor 2 (HER2)-expressing breast cancer lesions has been shown to allow early detection of HER2-positive pulmonary metastases and with more specificity than 18F-FDG, according to a study published online May 11 in the Journal of Nuclear Medicine.

Automated breast ultrasound one step closer to FDA approval

Regulatory News | Monday, May 14
U-Systems has received a pre-market approvable letter from the FDA for its somo•v Automated Breast Ultrasound (ABUS) system for breast cancer screening as an adjunct to mammography for asymptomatic women with dense breast tissue.

ASBD: JAMA brachytherapy study may mislead women

Clinical Studies | Tuesday, May 08
confused woman - 120.72 Kb
The American Society of Breast Disease (ASBD) has issued a statement contradicting information published in a study in the May 2 issue of Journal of the American Medical Association (JAMA), comparing breast brachytherapy to whole breast irradiation.

Public health key to improved cancer screening

Industry News | Tuesday, May 08
cancer - 14.97 Kb
Public health infrastructure should be leveraged and bolstered to improve current cancer screening rates and develop a comprehensive national approach to cancer control, according to an editorial published online May 9 in CA: A Cancer Journal for Clinicians.

JNM: SPECT/CT elevates interpretation of radioiodine scintigraphy

Clinical Studies | Friday, May 04
SPECT/CT Radioiodine Scintigraphy - 211.64 Kb
Source: J Nuc Med 2012;53:754-64
SPECT/CT is a powerful diagnostic tool that has improved interpretation of classic radioiodine scintigraphy, and current management protocols and guidelines in thyroid cancer should be reassessed in light of this new technology, according to an article published in the May issue of the Journal of Nuclear Medicine.

ARRS: Digital breast tomosynthesis slashes recall rates 40 percent

Clinical Studies | Friday, May 04
anxious woman - 273.92 Kb
Adding digital breast tomosynthesis to 2D mammography screening results in a 40 percent reduction in patient recall rates compared to routine screening mammography alone, according to a study presented May 3 at the annual meeting of the American Roentgen Ray Society (ARRS) in Vancouver.

Trial to assess lung cancer screening with combined CT, blood test

Clinical Studies | Friday, May 04
National Jewish Health in Denver is launching a lung cancer screening trial that will combine a CT chest scan and the EarlyCDT-Lung blood test, and will seek to build on recent research demonstrating that CT screening alone can reduce lung cancer mortality.

ARRS: Use of ABUS slashes physician time spent on breast cancer screening

Clinical Studies | Thursday, May 03
breast ultrasound, dense breast - 230.95 Kb
Source: U-Systems
Automated breast ultrasound allows for quick and more complete breast cancer screening of asymptomatic women with dense breast tissue, taking an average of three minutes of physician time, according to a study presented May 3 at the annual meeting of the American Roentgen Ray Society (ARRS) in Vancouver.

ARRS: Women with benign biopsies overmanaged

Clinical Studies | Tuesday, May 01
doctor and patient - 94.80 Kb
Contrary to current guidelines, women with benign breast biopsies do not need follow-up at six months, and they may not need close surveillance at all, according to research presented May 3 at the annual meeting of the American Roentgen Ray Society (ARRS) in Vancouver.

Senate bill seeks to curb 25% cut for same-day imaging

Government News | Monday, April 30
Capitol - 41.60 Kb
Senators Ben Cardin (D-Md.) and David Vitter (R-La.) introduced S. 2347, the Diagnostic Imaging Services Access Protection Act in the U.S. Senate on April 25.

ARRS: Lack of family history shouldn’t keep women 40-49 from yearly mammograms

Clinical Studies | Friday, April 27
breast cancer - 205.38 Kb
More than half the women aged 40 to 49 diagnosed with breast cancer on screening mammography reported no family history of the disease, supporting the benefit of yearly screening mammography for women in their 40s, according to a study presented May 3 at the annual meeting of the American Roentgen Ray Society in Vancouver.

ARRS: Disease risk outweighs risk of CT-induced cancer in young adults

Clinical Studies | Friday, April 27
radiation dose - 68.00 Kb
CT-induced cancer is always a concern when imaging younger patients, but an analysis of radiation risks has shown that young patients who undergo chest or abdominopelvic CT are more than 35 times more likely to die of their disease than develop a radiation-induced cancer, according to a study presented May 1 at the annual meeting of the American Roentgen Ray Society in Vancouver.

Most read articles in the past 30 days